Week in the industry has a great staff of dedicated editors, but we can’t write about everything. So here’s a compilation of news from many news brands from parent company Endeavor Business Media.
Eli Lilly To Invest $2.7 billion in US drug manufacturing sites to Threate Drug Tariffs: Pharma Manufacturing Editor-in-Chief Greg Slabodkin explores Eli Lilly’s investment in building four new US manufacturing sites. Lily hopes that in her upcoming drug tariff report, the $27 billion investment will strengthen the company’s supply chain. The site is expected to create more than 3,000 skilled jobs and begin manufacturing the drug within five years. Aviation products cancel three US-based projects. AIR Products has concluded its agreement with World Energy for California’s sustainable aviation fuel exhaust project, withdrew plans to build a green liquid hydrogen facility in New York, and has concluded its carbon monoxide production project in Texas. Learn more about why the company is withdrawing these projects from Amanda Joshi, a chemical processing management editor. Unitree releases Kung-Fu robots from the world: Unitree’s G1 humanoid robot can “perform dynamic movements like standing up, folding halfway, kicking a foot in the air, and rotating the torso 180 degrees,” writes Laura Davis, editor of the new equipment digest editor. Click on the link above to see which robots are running and see more details about their functionality. Economic Tug-of-War: How US tariffs form the healthcare supply market: hear from Charles Vartanian, Chief Supply Head of Rhino Medical Supply. Vartanian talks about the company’s history, common tariff misconceptions, and the challenges to reuse in the healthcare industry.
